• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要病灶切除术后残余同时性多发磨玻璃结节进展的预测因素

Predictors of residual simultaneous multiple ground-glass nodule progression after dominant lesion resection.

作者信息

Miyoshi Tomohiro, Tane Kenta, Samejima Joji, Aokage Keiju, Tsuboi Masahiro

机构信息

Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

出版信息

Gen Thorac Cardiovasc Surg. 2024 Mar;72(3):183-191. doi: 10.1007/s11748-023-01968-x. Epub 2023 Sep 7.

DOI:10.1007/s11748-023-01968-x
PMID:37676471
Abstract

OBJECTIVE

This study aimed to identify the predictive factors for the progression of residual simultaneous multifocal ground-glass nodules (SMGGNs) after resection of the dominant lesion.

METHODS

Patients (n = 3420) with primary lung cancer who underwent lung resections at our hospital between 2006 and 2016 were screened, and the data from 82 patients who had residual SMGGNs after undergoing surgery for the dominant lesion (pathologically stage 0-IIA) were retrospectively analyzed. Clinicopathological factors that predicted the growth of residual second dominant GGNs were identified.

RESULTS

Median total tumor and solid component sizes of the residual second dominant GGNs were 1.3 cm (interquartile range [IQR]: 0.6-2.0) and 0 cm (IQR: 0-0.7), respectively. During a median follow-up period of 54 months (IQR: 37-78 months), 35 (43%) lesions progressed. Logistic regression analysis revealed that age younger than 70 (OR: 10.54, 95% CI: 1.71-65.11), a dominant lesion with pure solid appearance (reference: GGN, OR: 18.16, 95% CI: 1.66-198.60), a second dominant GGN total size larger than 1.0 cm (OR: 12.27, 95% CI: 1.85-81.17), and a second dominant GGN solid component size larger than 0.5 cm (OR: 17.59, 95% CI: 3.58-86.47) were significant predictive factors for the progression of residual GGNs (all p values < 0.03). Based on an analysis of growth patterns, rapid growth was higher in second dominant GGNs with a part-solid appearance.

CONCLUSIONS

If the resected dominant lesion or the residual second dominant GGN exhibits high-risk factors, the second dominant GGN should be meticulously observed.

摘要

目的

本研究旨在确定切除主要病灶后残留的同时性多灶性磨玻璃结节(SMGGNs)进展的预测因素。

方法

筛选2006年至2016年间在我院接受肺切除术的原发性肺癌患者(n = 3420),并对82例在接受主要病灶手术(病理分期为0-IIA)后有残留SMGGNs的患者数据进行回顾性分析。确定预测残留的第二大主要磨玻璃结节(GGN)生长的临床病理因素。

结果

残留的第二大主要GGN的肿瘤总大小和实性成分大小的中位数分别为1.3 cm(四分位间距[IQR]:0.6-2.0)和0 cm(IQR:0-0.7)。在中位随访期54个月(IQR:37-78个月)内,35个(43%)病灶进展。逻辑回归分析显示,年龄小于70岁(比值比[OR]:10.54,95%置信区间[CI]:1.71-65.11)、主要病灶为纯实性外观(参照:GGN,OR:18.16,95%CI:1.66-198.60)、第二大主要GGN总大小大于1.0 cm(OR:12.27,95%CI:1.85-81.17)以及第二大主要GGN实性成分大小大于0.5 cm(OR:17.59,95%CI:3.58-86.47)是残留GGN进展的显著预测因素(所有p值<0.03)。基于生长模式分析,部分实性外观的第二大主要GGN快速生长的比例更高。

结论

如果切除的主要病灶或残留的第二大主要GGN具有高危因素,则应仔细观察第二大主要GGN。

相似文献

1
Predictors of residual simultaneous multiple ground-glass nodule progression after dominant lesion resection.主要病灶切除术后残余同时性多发磨玻璃结节进展的预测因素
Gen Thorac Cardiovasc Surg. 2024 Mar;72(3):183-191. doi: 10.1007/s11748-023-01968-x. Epub 2023 Sep 7.
2
Clinical Outcomes of Resected Pure Ground-Glass, Heterogeneous Ground-Glass, and Part-Solid Pulmonary Nodules.切除纯磨玻璃、混杂性磨玻璃和部分实性肺结节的临床结果。
AJR Am J Roentgenol. 2024 May;222(5):e2330504. doi: 10.2214/AJR.23.30504. Epub 2024 May 15.
3
A decrease in the size of ground glass nodules may indicate the optimal timing for curative surgery.磨玻璃结节大小的减小可能表明进行根治性手术的最佳时机。
Lung Cancer. 2014 Aug;85(2):213-7. doi: 10.1016/j.lungcan.2014.05.015. Epub 2014 May 21.
4
Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas.磨玻璃结节为主型与单发病灶型肺腺癌术后比较结果
J Cardiothorac Surg. 2020 Jun 22;15(1):149. doi: 10.1186/s13019-020-01196-x.
5
Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.直径小于2cm的纯磨玻璃密度肺结节的肺腺癌侵袭风险
Thorac Cardiovasc Surg. 2019 Jun;67(4):321-328. doi: 10.1055/s-0037-1612615. Epub 2018 Jan 22.
6
Surgically resected lung adenocarcinoma: do heterogeneous GGNs and part-solid nodules on thin-section CT show different prognosis?手术切除的肺腺癌:薄层 CT 上表现为混杂性磨玻璃结节和部分实性结节的患者是否具有不同的预后?
Jpn J Radiol. 2023 Feb;41(2):164-171. doi: 10.1007/s11604-022-01345-3. Epub 2022 Oct 11.
7
Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity.多发磨玻璃密度肺结节的自然病史和临床特征。
Respirology. 2017 Nov;22(8):1615-1621. doi: 10.1111/resp.13089. Epub 2017 Jun 13.
8
Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Scanning Change.定量 CT 扫描分析纯磨玻璃密度结节预测进一步 CT 扫描变化。
Chest. 2016 Jan;149(1):180-91. doi: 10.1378/chest.15-0034. Epub 2016 Jan 6.
9
Preoperative flexible bronchoscopy in patients with persistent ground-glass nodule.持续性磨玻璃结节患者的术前柔性支气管镜检查
PLoS One. 2015 Mar 24;10(3):e0121250. doi: 10.1371/journal.pone.0121250. eCollection 2015.
10
Natural Progression of Ground-glass Nodules after Curative Resection for Non-small Cell Lung Cancer.非小细胞肺癌根治性切除术后磨玻璃结节的自然演变。
J Korean Med Sci. 2021 Nov 8;36(43):e266. doi: 10.3346/jkms.2021.36.e266.

引用本文的文献

1
Risk factors for the growth of ground-glass nodules in the lungs: A systematic review and meta-analysis.肺部磨玻璃结节生长的危险因素:一项系统评价和荟萃分析。
Clinics (Sao Paulo). 2025 May 7;80:100669. doi: 10.1016/j.clinsp.2025.100669. eCollection 2025.

本文引用的文献

1
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.肺内磨玻璃密度结节直径≤3cm 包括磨玻璃成分的肺癌行局部切除术(JCOG1211):一项多中心、单臂、阳性、III 期临床试验
Lancet Respir Med. 2023 Jun;11(6):540-549. doi: 10.1016/S2213-2600(23)00041-3. Epub 2023 Mar 6.
2
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.小型周围型非小细胞肺癌的肺段切除术与肺叶切除术比较(JCOG0802/WJOG4607L):一项多中心、开放标签、3期、随机、对照、非劣效性试验
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
3
Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study).前瞻性评估磨玻璃密度早期肺癌的观察等待策略:单臂确证性多中心研究:日本临床肿瘤学组研究 JCOG1906(常绿研究)。
Jpn J Clin Oncol. 2021 Aug 1;51(8):1330-1333. doi: 10.1093/jjco/hyab074.
4
A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.亚肺叶切除术治疗以磨玻璃密度影为主要表现的周围型肺癌的单臂研究。
J Thorac Cardiovasc Surg. 2022 Jan;163(1):289-301.e2. doi: 10.1016/j.jtcvs.2020.09.146. Epub 2020 Nov 12.
5
Clinical features and outcomes of patients with stage I multiple primary lung cancers.Ⅰ期多原发肺癌患者的临床特征和转归。
Cancer Sci. 2021 May;112(5):1924-1935. doi: 10.1111/cas.14748. Epub 2021 Mar 9.
6
Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.临床ⅠA 期非小细胞肺癌磨玻璃密度成分的预后影响。
J Thorac Cardiovasc Surg. 2021 Apr;161(4):1469-1480. doi: 10.1016/j.jtcvs.2020.01.107. Epub 2020 Apr 6.
7
Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.基于磨玻璃密度成分的多原发性肺癌的预后分类。
Ann Thorac Surg. 2020 Feb;109(2):420-427. doi: 10.1016/j.athoracsur.2019.09.008. Epub 2019 Oct 5.
8
Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.临床Ⅰ期非小细胞肺癌患者磨玻璃密度影及其相应的病理结果对生存的影响。
J Thorac Oncol. 2018 Apr;13(4):533-542. doi: 10.1016/j.jtho.2017.11.129. Epub 2017 Dec 13.
9
Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers.手术治疗多原发性肺癌患者具有良好的预后和高度的遗传特征差异。
J Thorac Cardiovasc Surg. 2018 Jan;155(1):371-379.e1. doi: 10.1016/j.jtcvs.2017.08.141. Epub 2017 Oct 5.
10
Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.磨玻璃影成分对非小细胞肺癌临床 T 分期的预后影响。
J Thorac Cardiovasc Surg. 2017 Dec;154(6):2102-2110.e1. doi: 10.1016/j.jtcvs.2017.08.037. Epub 2017 Sep 1.